Global Market News

Pharma defeats biotech push for rapid approval program

2/2/2012

Biotechs butted heads with their far-larger pharmaceutical allies over a key lobbying issue, and lost. As Bloomberg reports, biotechnology companies threw their weight behind a plan drafted by North Carolina Democratic Sen. Kay Hagan to launch a more rapid FDA approval program, using fewer human trials, for orphan drugs or treatments that address fatal diseases. Pharmaceutical companies beat back the measure, however, apparently not wanting to dilute existing safety measures
 

Fierce BioTech



Return to Previous Page

Today Is:
Wednesday, August 27, 2014


August Events

<< >>
SMTWTFS
12
3456789
10111213141516
17181920212223
24252627282930
31